- QuidelOrtho's 2023 adjusted diluted earnings per share and revenue outlook ranges include the consensus estimates.
- The healthcare testing and diagnostics maker is expecting adjusted diluted EPS this year of $5.00-$5.60 ($5.19 consensus) and revenue of $2.8B-$3.1B ($2.81B consensus).
- In a presentation accompanying its Q4 2022 earnings call Wednesday afternoon, QuidelOrth ( NASDAQ: QDEL ) said that it is confident it will be able to deliver high-single-digit top-line growth over the long-term.
- In Q4 2022, the company beat on the top and bottom lines .
- However, revenue and especially net income saw declines year over year due to a decline in COVID-19 testing. In the quarter, net income was $30.3M. In Q4 2021, it was $291.3M.
- The company ended 2022 with cash and cash equivalents of $292.9M, compared to $802.8M at the end of 2021.
- Read why Seeking Alpha contributor Khaveen Investments considers QuidelOrtho ( QDEL ) a strong buy.
For further details see:
QuidelOrtho 2023 earnings per share, revenue guidance range includes consensus